After 50 hearings, court reserves judgement in Daiichi-Fortis case

Daiichi is seeking enforcement of an arbitration award in favour of it against former Fortis promoters Malvinder and Shivinder Mohan Singh for alleged fraud in the 2008 sale of their pharma company Ranbaxy Laboratories to the Japanese firm. Including interest, the amount that a Singapore tribunal awarded a decade ago has now swelled to ₹5,200 crore.